Valeant invests in Rochester.

The article reports that Valeant Pharmaceuticals International Inc. has started a new manufacturing line in the U.S. for its Ultra range of contact lenses. It presents the views of Michael Pearson, Valeant chairman and chief executive officer, who says the firm's Rochester facility is a very important piece of strategy to rebuild its eye health products supplier Bausch+Lomb as one of the leading contact lens producers.